Cancer Archives

News and Trends 2 Sep 2022

Cancer drug for children and young people with glioblastoma given to patients in study

Clinical-stage bio company, Onxeo, has announced that the first patients have been enrolled and treated in a phase 1b/2 clinical study. The study is to evaluate the efficacy and tolerability of AsiDNA2, a DDR inhibitor combined with radiotherapy in children, adolescents or young adults with relapsed high grade glioma (HGG). Onxeo, which focuses on drugs […]

September 2, 2022 - 3 minutesmins - By Liza Laws

News and Trends 2 Sep 2022

Beyond Biotech podcast 12: Gate Neurosciences, Oncolyze, 3Brain

This week’s podcast guests are Mike McCully, CEO of Gate Neurosciences; Steven Evans, CEO and co-founder of Oncolyze; and Philipp Markolin, scientific marketing specialist at 3Brain. We also have our weekly chat with global commercial real estate services company JLL, and this week it’s a chat with Amber Schiada, head of life sciences research in […]

September 2, 2022

News and Trends 1 Sep 2022

New discovery could lead to drug development for brain cancer

According to researchers, a study at Tel Aviv University in Israel effectively eradicated glioblastoma, a highly lethal type of brain cancer. The researchers achieved the outcome using a method they developed based on their discovery of two critical mechanisms in the brain that support tumor growth and survival: one protects cancer cells from the immune […]

September 1, 2022 - 6 minutesmins - By Jim Cornall

News and Trends 1 Sep 2022

Proxidrugs: a new tool to fight pathogens?

Scientists at the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP in Germany are working with partners to develop a new drug class. Proxidrugs (or proximity-inducing drugs) utilize cells’ waste disposal system as potential new treatments for cancer, infections and Alzheimer’s disease. Aimo Kannt, head of drug discovery and preclinical research at Fraunhofer ITMP in […]

September 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Sep 2022

License agreement signed allowing drug to treat mycosis fungoides to expand in Asia, Australia and the Middle East

A license agreement has been signed between Helsinn Group and Juniper Biologics further widening the scope for distribution of T-cell lymphoma treatment, LEGADA. The license signifies a supply agreement to register, distribute, promote, market and sell the drug in Australia, Asia and the Middle East as a topical treatment of the mycosis fungoides-type cutaneous T-cell […]

September 1, 2022 - 3 minutesmins - By Liza Laws

News and Trends 31 Aug 2022

Anti-cancer drug created from reprogrammed yeast

Engineered yeast cells can synthetically produce the essential cancer medicine vinblastine, an international team of scientists showed in a new study published in Nature. In the summer and fall of 2019, some cancer patients experienced interruptions in their treatment. The reason was a shortage of the drugs vinblastine and vincristine, essential chemotherapeutic medicines for several […]

August 31, 2022 - 5 minutesmins - By Jim Cornall

Sanofi drops amcenestrant clinical development program

News and Trends 30 Aug 2022

Potential new cancer treatment target discovered by researchers in Sweden

A previously unknown mechanism that can control tumor growth in cultured cells and mice has been identified by researchers at the University of Gothenburg, Sweden. This discovery may potentially enable future development of new drugs against a range of cancer diseases. In a research article published in the journal Nature Communications, the Gothenburg scientists described […]

August 30, 2022 - 2 minutesmins - By Liza Laws

News and Trends 30 Aug 2022

Artificial intelligence-based algorithm to be used for reporting of lymph node status in colon cancer

A collaboration looking at the development of an artificial intelligence (AI)-based digital pathology solution to detect cancer within lymph nodes from colorectal surgery cases has been announced today (August 30). Indica Labs, which works in quantitative digital pathology and image management solutions, has joined forces with The Industrial Centre for Artificial Intelligence Research in Digital […]

August 30, 2022 - 3 minutesmins - By Liza Laws

News and Trends 29 Aug 2022

Strategic collaboration announced in China to accelerate the development of bacterial drugs

A strategic cooperation between Porton Advanced Solutions and Suzhou Royaltech Med Co., Ltd was announced today (August 29). The companies say the collaboration which was agreed earlier in the month (August 19) is set to integrate the resources and capabilities of both parties. The say it will jointly promote the establishment of microbial vectors used […]

August 29, 2022 - 2 minutesmins - By Liza Laws

News and Trends 26 Aug 2022

Aktis Oncology raises millions in funding bringing total to $161M

Aktis Oncology announced yesterday (August 25) that it has raised a series A extension financing of $84 million bringing its total capital raised to date to $161 million. The Massachusetts-based company develops targeted alpha radiopharmaceuticals to treat a broad range of solid tumors. Aktis Oncology‘s investors The extension included participation from new health investors Cowen […]

August 26, 2022 - 2 minutesmins - By Liza Laws

coronavirus COVID 19 Europe biotech lungs

News and Trends 25 Aug 2022

Alpha Biopharma announces completion of phase 2/3 clinical study for drug to treat lung cancer

Patients with advanced EGFRm+ non-small cell lung cancer (NSCLC) with central nervous system (CNS) metastases have completed their last visit in a clinical trial studying the drug, Zorifertinib. Drugs developer, Alpha Biopharma, announced the completion today (August 25) of last patient last visit (LPLV) in its international, multicenter EVEREST phase 2/3 study of the next-generation […]

August 25, 2022 - 3 minutesmins - By Liza Laws

News and Trends 25 Aug 2022

3T Biosciences launches with $40M financing

3T Biosciences wants to change the future of treatment for solid tumors and other immune-mediated diseases. And it exited from stealth today backed by $40 million in series A financing led by Westlake Village BioPartners with participation from Lightspeed Venture Partners. Proceeds from the financing will be used to help accelerate 3T Biosciences from a […]

August 25, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Cancer drug for children and young people with glioblastoma given to patients in study

Beyond Biotech podcast 12: Gate Neurosciences, Oncolyze, 3Brain

New discovery could lead to drug development for brain cancer

Proxidrugs: a new tool to fight pathogens?

License agreement signed allowing drug to treat mycosis fungoides to expand in Asia, Australia and the Middle East

Anti-cancer drug created from reprogrammed yeast

Potential new cancer treatment target discovered by researchers in Sweden

Artificial intelligence-based algorithm to be used for reporting of lymph node status in colon cancer

Strategic collaboration announced in China to accelerate the development of bacterial drugs

Aktis Oncology raises millions in funding bringing total to $161M

Alpha Biopharma announces completion of phase 2/3 clinical study for drug to treat lung cancer

3T Biosciences launches with $40M financing

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!